DE3782276T2 - Interleukin-2 induziertes antineoplastisches peptid. - Google Patents

Interleukin-2 induziertes antineoplastisches peptid.

Info

Publication number
DE3782276T2
DE3782276T2 DE8787304883T DE3782276T DE3782276T2 DE 3782276 T2 DE3782276 T2 DE 3782276T2 DE 8787304883 T DE8787304883 T DE 8787304883T DE 3782276 T DE3782276 T DE 3782276T DE 3782276 T2 DE3782276 T2 DE 3782276T2
Authority
DE
Germany
Prior art keywords
peptides
interleukin
polypeptides
induced
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787304883T
Other languages
English (en)
Other versions
DE3782276D1 (de
Inventor
Daniel R Twardzik
Karl Eric Hellstrom
Ingegerd Hellstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of DE3782276D1 publication Critical patent/DE3782276D1/de
Application granted granted Critical
Publication of DE3782276T2 publication Critical patent/DE3782276T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718Cytokine-induced proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/91Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8787304883T 1986-06-04 1987-06-03 Interleukin-2 induziertes antineoplastisches peptid. Expired - Fee Related DE3782276T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87044086A 1986-06-04 1986-06-04

Publications (2)

Publication Number Publication Date
DE3782276D1 DE3782276D1 (de) 1992-11-26
DE3782276T2 true DE3782276T2 (de) 1993-03-04

Family

ID=25355375

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787304883T Expired - Fee Related DE3782276T2 (de) 1986-06-04 1987-06-03 Interleukin-2 induziertes antineoplastisches peptid.

Country Status (9)

Country Link
EP (1) EP0248642B1 (de)
JP (1) JPS6322100A (de)
AT (1) ATE81591T1 (de)
AU (1) AU612575B2 (de)
CA (1) CA1320906C (de)
DE (1) DE3782276T2 (de)
ES (1) ES2052562T3 (de)
GR (1) GR3006212T3 (de)
IL (1) IL82734A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196958B (it) * 1986-07-10 1988-11-25 Ellem Ind Farmaceutica Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
CN111757745B (zh) 2018-02-01 2022-11-04 Nkmax有限公司 产生天然杀伤细胞的方法和用于治疗癌症的组合物

Also Published As

Publication number Publication date
GR3006212T3 (de) 1993-06-21
DE3782276D1 (de) 1992-11-26
CA1320906C (en) 1993-08-03
IL82734A (en) 1992-05-25
EP0248642A2 (de) 1987-12-09
JPS6322100A (ja) 1988-01-29
AU7378087A (en) 1987-12-10
ATE81591T1 (de) 1992-11-15
ES2052562T3 (es) 1994-07-16
EP0248642A3 (en) 1989-11-02
IL82734A0 (en) 1987-12-20
EP0248642B1 (de) 1992-10-21
AU612575B2 (en) 1991-07-18

Similar Documents

Publication Publication Date Title
FI90983C (fi) Menetelmä yhdistelmäinterferonipolypeptidien valmistamiseksi
ES2060603T3 (es) El uso de la proteina vp6 nucleocapsida de rotavirus en composiciones de vacunas.
ES2088858T3 (es) Proteina interleuquina-4 que tiene actividad de factor de crecimiento de celulas b(bcgf) y de factor de crecimiento de celulas t(tcgf) en celulas humanas (interleuquina-4 humana).
ATE350386T1 (de) Elk ligand, ein cytokin
IE862072L (en) Oxa- and azahomocyclostatine polypeptides and related¹intermediates
NO854460L (no) Syntetisk hepatitis-b-vaksine inbefattende baade t-celle og b-celledeterminanter.
ES533485A0 (es) Procedimiento para producir un vehiculo de expresion de adn-replicable.
FI902880A0 (fi) Polypeptider och polypeptidanaloger.
DE68917837D1 (de) Peptid-Verbindungen.
DE3782276D1 (de) Interleukin-2 induziertes antineoplastisches peptid.
DE69032323T2 (de) Produktion und verwendung von antihelmintischen substanzen und schützenden immunogenen
DK262986A (da) Peptidmateriale med thymushumoral aktivitet
ES2044928T3 (es) Enzima alfa-amidante en terminal c y procedimiento para la produccion y el uso del mismo.
ATE81134T1 (de) Peptide.
NO894573D0 (no) Rekombinante interleukin-2 hybridproteiner.
AU525042B2 (en) Ovulation enhancing peptides
ATE20669T1 (de) Antigene lineare peptidverbindungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee